SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-22-000019
Filing Date
2022-08-03
Accepted
2022-08-03 06:03:41
Documents
79
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20220630.htm   iXBRL 10-Q 2210889
2 EX-10.1 uthrex10106302022.htm EX-10.1 458767
3 EX-10.3 uthrex10306302022.htm EX-10.3 16925
4 EX-31.1 uthrex31106302022.htm EX-31.1 11703
5 EX-31.2 uthrex31206302022.htm EX-31.2 11709
6 EX-32.1 uthrex32106302022.htm EX-32.1 6568
7 EX-32.2 uthrex32206302022.htm EX-32.2 6695
  Complete submission text file 0001082554-22-000019.txt   9813825

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20220630.xsd EX-101.SCH 52440
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20220630_cal.xml EX-101.CAL 77738
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20220630_def.xml EX-101.DEF 304409
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20220630_lab.xml EX-101.LAB 709807
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20220630_pre.xml EX-101.PRE 459900
73 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20220630_htm.xml XML 1760145
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 221130785
SIC: 2834 Pharmaceutical Preparations